Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at [email protected] Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Jubilant Wins Relief: Allahabad HC Bars Pharma Firms from Using Its Drug Dossier

USFDA issues 4 observations for Jubilant Generics Roorkee facility

Written By Ruchika Sharma2 Aug 2025 11:27 AM IST

Noida: Jubilant Pharmova Limited has announced that the United States Food and Drug Administration (USFDA) has issued 4 observations at the conclusion...

Johnson and Johnson Gets CDSCO Panel Nod for Talqetamab in Relapsed Multiple Myeloma, Phase IV Trial Mandated

JnJ seeks USFDA approval for Tremfya label update

Written By Ruchika Sharma30 July 2025 3:30 PM IST

Submission is supported by 24-week results from the Phase 3b APEX study in adults with active psoriatic arthritis treated with TREMFYA.

Sanofi India appoints Haresh Vala as Company Secretary, Compliance Officer

Sanofi earns orphan drug designation from USFDA for multiple myeloma drug

Written By Ruchika Sharma30 July 2025 1:30 PM IST

Paris: Sanofi has received orphan drug designation from the US Food and Drug Administration (FDA) for SAR446523, an IgG1-based...

Palamur Biosciences Faces USFDA Warning for Multiple GLP Compliance Failures

AbbVie seeks USFDA nod for combination regimen of Venclexta, Acalabrutinib for previously untreated patients with Chronic Lymphocytic Leukemia

Written By Ruchika Sharma30 July 2025 11:29 AM IST

VENCLEXTA is being developed by AbbVie and Roche.

GSKs Mo-rez Shows Strong Tumor Reduction Data, Tipped as Potential Blockbuster Cancer Drug

GSK, Hengrui Pharma to develop up to 12 medicines across Respiratory, Immunology & Inflammation and Oncology

Written By Ruchika Sharma29 July 2025 2:30 PM IST

London: GSK plc has announced it has entered into agreements with Hengrui Pharma (600276.SH; 01276.HK) to develop up to 12 innovative medicines,...

Aarti Pharmalabs Gets Single Observation in USFDA Inspection at Tarapur Unit

AstraZeneca Imfinzi gets USFDA priority review for resectable early stage gastric, gastroesophageal junction cancers

Written By Ruchika Sharma29 July 2025 1:30 PM IST

Cambridge: AstraZeneca has announced that the company's supplemental Biologics License Application (sBLA) for Imfinzi (durvalumab) has...

Bristol Myers Squibb, Bain Capital form new biopharmaceutical company - NewCo

Written By Ruchika Sharma29 July 2025 12:30 PM IST

Princeton: Bristol Myers Squibb and Bain Capital have announced the formation of a new independent biopharmaceutical company, NewCo, focused on...

Bayer Finerenone approved in Japan for chronic heart failure

Bayer Sevabertinib accepted for review in China for advanced non-small cell lung cancer

Written By Ruchika Sharma29 July 2025 11:30 AM IST

Berlin: Bayer has announced that the Center for Drug Evaluation (CDE) of China's National Medical Products Administration (NMPA) has accepted for...

Boehringer Ingelheims Vetmedin Becomes First USFDA-Approved Drug to Delay Heart Failure in Dogs

Boehringer Ingelheim, Re-Vana Therapeutics ink pact to develop extended release therapies for eye diseases

Written By Ruchika Sharma29 July 2025 9:00 AM IST

Ingelheim: Boehringer Ingelheim and Re-Vana Therapeutics, a US and UK-based developer of ocular therapeutics and ocular drug delivery...

Lupin, Sun Pharma and 1 other recall products in US

Written By Ruchika Sharma28 July 2025 2:45 PM IST

New Delhi: Leading pharmaceutical companies, Sun Pharma, Dr Reddy's Laboratories and Lupin are recalling products from the US market...

Roche gets negative EMA Committee opinion on Elevidys CMA for 3-7 year olds with Duchenne muscular dystrophy

Written By Ruchika Sharma27 July 2025 4:15 PM IST

Basel: Roche has announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a...

Roche Expands AI Capabilities with 2,100+ Nvidia Chips to Accelerate Drug Development

Roche receives CE Mark for minimally invasive blood test to help rule out Alzheimer's disease

Written By Ruchika Sharma27 July 2025 3:15 PM IST

Basel: Roche has announced it has received CE Mark for its Elecsys pTau181 test to measure phosphorylated Tau (pTau) 181 protein which is an...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok